Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment".
Saved in:
| Title: | Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment". |
|---|---|
| Authors: | Das R; Moderna, Inc, Cambridge, MA, USA., Hyer RN; Baruch S. Blumberg Institute, Doylestown, PA, USA., Burton P; Moderna, Inc, Cambridge, MA, USA., Miller JM; Moderna, Inc, Cambridge, MA, USA., Kuter BJ; Moderna, Inc, Cambridge, MA, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2195333. Date of Electronic Publication: 2023 Apr 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2023.2195333 |
